awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35992243-0A1D9A4E-338F-4622-B2D6-F5F9F4CA0511
Q35992243-0A1D9A4E-338F-4622-B2D6-F5F9F4CA0511
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35992243-0A1D9A4E-338F-4622-B2D6-F5F9F4CA0511
Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial.
P2860
Q35992243-0A1D9A4E-338F-4622-B2D6-F5F9F4CA0511
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35992243-0A1D9A4E-338F-4622-B2D6-F5F9F4CA0511
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7256ed2f8867bc44b3209611e5c673cfda96439c
P2860
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.